A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps
Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial
to evaluate the efficacy, safety and pharmacokinetics of TQC2731 injection in the treatment
of Chronic Sinusitis with Nasal Polyps.